- Home
- CPRX vs BUR Comparison
CPRX vs BUR Comparison
Compare CPRX & BUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- BUR
- Stock Information
- Founded
- CPRX 2002
- BUR 2009
- Country
- CPRX United States
- BUR Guernsey
- Employees
- CPRX N/A
- BUR N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- BUR Finance: Consumer Services
- Sector
- CPRX Health Care
- BUR Finance
- Exchange
- CPRX Nasdaq
- BUR Nasdaq
- Market Cap
- CPRX 2.6B
- BUR 3.0B
- IPO Year
- CPRX 2006
- BUR 2010
- Fundamental
- Price
- CPRX $20.59
- BUR $13.98
- Analyst Decision
- CPRX Strong Buy
- BUR Strong Buy
- Analyst Count
- CPRX 5
- BUR 2
- Target Price
- CPRX $33.20
- BUR $18.00
- AVG Volume (30 Days)
- CPRX 1.5M
- BUR 1.4M
- Earning Date
- CPRX 08-06-2025
- BUR 08-07-2025
- Dividend Yield
- CPRX N/A
- BUR 0.89%
- EPS Growth
- CPRX 183.96
- BUR N/A
- EPS
- CPRX 1.65
- BUR 1.08
- Revenue
- CPRX $558,499,000.00
- BUR $443,251,000.00
- Revenue This Year
- CPRX $16.51
- BUR $17.08
- Revenue Next Year
- CPRX $9.58
- BUR $9.43
- P/E Ratio
- CPRX $12.45
- BUR $12.96
- Revenue Growth
- CPRX 28.55
- BUR N/A
- 52 Week Low
- CPRX $19.00
- BUR $10.70
- 52 Week High
- CPRX $26.58
- BUR $15.73
- Technical
- Relative Strength Index (RSI)
- CPRX 48.79
- BUR 53.77
- Support Level
- CPRX $19.83
- BUR $13.53
- Resistance Level
- CPRX $21.82
- BUR $14.14
- Average True Range (ATR)
- CPRX 0.57
- BUR 0.37
- MACD
- CPRX 0.07
- BUR 0.02
- Stochastic Oscillator
- CPRX 45.33
- BUR 81.22
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About BUR Burford Capital Limited
Burford Capital Ltd is a finance firm providing litigation finance, insurance, and risk transfer, law firm lending, corporate intelligence and judgment enforcement, and a wide range of investment activities. It operates in two segments: Principal Finance, which allocates capital to legal finance assets from its balance sheet, primarily as capital provision assets and in limited scope through interests in private funds managed by the company; Asset management and other services, which includes the provision of services to the legal industry, including litigation insurance; and other corporate. The geographical segments include the United States, United Kingdom, Singapore, Hong Kong, China, and, Australia.